These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8472623)

  • 1. Immunological resistance to human biosynthetic insulin--effects of immunosuppression and plasmapheresis.
    Micić D; Brkić S; Kendereski A; Popović V; Zorić S; Nikolić JA; Igrutinović L; Ivanoska D; Manojlović D; Micić J
    Diabetes Res Clin Pract; 1993 Jan; 19(1):83-9. PubMed ID: 8472623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible effectiveness of plasmapheresis and immunosuppressive therapy in reversing subcutaneous insulin resistance: a case report.
    Vannini P; Forlani G; Giangiulio S; Santacroce G; Ciavarella A; Mustacchio A
    Diabete Metab; 1989; 15(2):98-101. PubMed ID: 2500372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
    Silverstein J; Maclaren N; Riley W; Spillar R; Radjenovic D; Johnson S
    N Engl J Med; 1988 Sep; 319(10):599-604. PubMed ID: 3045545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Diabetic Ketoacidosis and Extreme Insulin Resistance Due to Anti-Insulin Antibodies: Response to Immunosuppression and Plasma Exchange.
    Ahmed M; Subbalaxmi MVS; Anne B; Deme S
    Diabetes Technol Ther; 2021 Mar; 23(3):227-229. PubMed ID: 33016111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe insulin resistance secondary to insulin antibodies: successful treatment with the immunosuppressant MMF.
    Segal T; Webb E; Viner R; Pusey C; Wild G; Allgrove J
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):250-4. PubMed ID: 18547238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistance.
    Schernthaner G
    Diabetes Care; 1982; 5 Suppl 2():114-8. PubMed ID: 6765520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy.
    Zhuang Y; Wei X; Yu Y; Wang D
    J Clin Apher; 2021 Aug; 36(4):664-667. PubMed ID: 34013991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.
    Tan-Lim R; Bystryn JC
    J Am Acad Dermatol; 1990 Jan; 22(1):35-40. PubMed ID: 2298963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy.
    Greenfield JR; Tuthill A; Soos MA; Semple RK; Halsall DJ; Chaudhry A; O'Rahilly S
    Diabet Med; 2009 Jan; 26(1):79-82. PubMed ID: 19125765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intractable diabetic ketoacidosis due to insulin antibody--response to steroid therapy.
    Chang TC; Jap TS; Kwok CF; Won JG; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Feb; 45(2):83-6. PubMed ID: 2168254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.
    Eriksson JW; Bremell T; Eliasson B; Fowelin J; Fredriksson L; Yu ZW
    Diabetes Care; 1998 Aug; 21(8):1217-20. PubMed ID: 9702422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis as a steroid saving procedure in bullous pemphigoid.
    Egan CA; Meadows KP; Zone JJ
    Int J Dermatol; 2000 Mar; 39(3):230-5. PubMed ID: 10759969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: a case report.
    Yamamoto T; Sato T; Mori T; Yamakita T; Hasegawa T; Miyamoto M; Hosoi M; Ishii T; Yoshioka K; Tanaka S; Fujii S
    Diabetes Res Clin Pract; 2000 Jul; 49(1):65-9. PubMed ID: 10808065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis in myasthenia gravis.
    Dau PC
    Prog Clin Biol Res; 1982; 88():265-85. PubMed ID: 7100216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of cold haemoglobinuria with later sarcoidosis. Treatment with plasmapheresis and immunosuppressiva.
    Andersen E; Skov F; Hippe E
    Scand J Haematol; 1980 Jan; 24(1):47-50. PubMed ID: 7367831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-Mediated Extreme Insulin Resistance: A Report of Three Cases.
    Kim HN; Fesseha B; Anzaldi L; Tsao A; Galiatsatos P; Sidhaye A
    Am J Med; 2018 Jan; 131(1):102-106. PubMed ID: 28822702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a short prednisone regime at clinical onset of type 1 diabetes.
    Goday A; Pujol-Borrell R; Fernandez J; Casamitjana R; Rios M; Vilardell E; Gomis R
    Diabetes Res Clin Pract; 1993 Apr; 20(1):39-46. PubMed ID: 8344127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine.
    Fine JD; Appell ML; Green LK; Sams WM
    Arch Dermatol; 1988 Feb; 124(2):236-9. PubMed ID: 3277542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance and allergy to recombinant human insulin.
    Ganz MA; Unterman T; Roberts M; Uy R; Sahgal S; Samter M; Grammer LC
    J Allergy Clin Immunol; 1990 Jul; 86(1):45-51. PubMed ID: 2196303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.